GAM Multistock - Swiss Equity CHF BRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 13.9 | 26.9 | -16.7 | 18.5 | 0.0 | |
+/-Cat | 3.4 | 6.9 | -7.9 | 7.6 | 0.0 | |
+/-B’mrk | - | 4.5 | -9.5 | 9.9 | 0.2 | |
Category: Switzerland Equity | ||||||
Category Benchmark: Morningstar Switzerland TME... |
Key Stats | ||
NAV 18/04/2024 | CHF 1005.55 | |
Day Change | 0.22% | |
Morningstar Category™ | Switzerland Equity | |
ISIN | LU0026741651 | |
Fund Size (Mil) 17/04/2024 | CHF 205.20 | |
Share Class Size (Mil) 17/04/2024 | CHF 115.96 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 20/02/2023 | 1.50% |
Investment Objective: GAM Multistock - Swiss Equity CHF B |
The investment objective of the Company is to achieve long-term capital growth by investing at least two thirds of the fund’s assets in a portfolio of carefully selected shares, other equity securities and warrants on shares and equity securities (up to a maximum of 15% of the assets of the Subfund) of companies with their registered office or major part of their business activities in Switzerland. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Daniel Häuselmann 01/05/2006 | ||
Inception Date 28/11/1991 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
SIX SPI TR CHF | Morningstar Switzerland TME NR CHF |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for GAM Multistock - Swiss Equity CHF B | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novartis AG Registered Shares | Healthcare | 8.01 |
Nestle SA | Consumer Defensive | 6.00 |
Holcim Ltd | Basic Materials | 5.47 |
Roche Holding AG | Healthcare | 5.12 |
UBS Group AG | Financial Services | 5.03 |
Increase Decrease New since last portfolio | ||
GAM Multistock - Swiss Equity CHF B |